Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Narayana Hrudayalaya...

    Narayana Hrudayalaya Q4FY17 standalone net profit rises 31%

    Written by Ruby Khatun Khatun Published On 2017-06-02T18:27:48+05:30  |  Updated On 2 Jun 2017 6:27 PM IST
    Narayana Hrudayalaya Q4FY17 standalone net profit rises 31%

    Bengaluru: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, announced its financial results for the fourth quarter (Q4 FY17) and full year (FY17) ended March 31st, 2017.


    Narayan Hrudaylay Ltd. standalone revenue for the quarter came in at Rs. 427.3 crore, registering 10.6% yoy increase.


    EBITDA for the quarter rose by 6.6% yoy to Rs. 50.85 crore with a corresponding margin contraction of 44 bps. EBITDA margin for the quarter stood at 11.9%.

    The PAT for the quarter came in at Rs. 24.24 crore, yoy increase of 31%.

    Looking at the full year numbers, we see that revenue jumped by 12% to reach Rs.1645.9 crore while EBITDA rose by 25% to 212.38 crore. The company reported net profit of Rs.95.1 crore, up 68% yoy

    Financial Highlights for the Quarter (Q4 FY17) - Prepared in accordance with Ind AS (‘Indian Accounting Standards’)




    • Consolidated total operating income was Rs. 4,835 mn as against Rs. 4,276 mn in Q4 FY16, reflecting an increase of 13.1%

    • Consolidated EBITDA stood at Rs. 659 mn as compared to Rs. 534 mn in Q4 FY16, reflecting an increase of 23.4%

    • Consolidated EBITDA Margin was at 13.6% as against 12.5% in Q4 FY16, showing an improvement by 114 basis points (bps)

    • PAT after minority interest and share in loss in associate stood at Rs. 223 mn as compared to Rs. 50 mn in Q4 FY16


    Financial Highlights for the full year (FY17)




    • Consolidated total operating income was Rs. 18,782 mn as against Rs. 16,138 mn in FY16, reflecting an increase of 16.4%

    • Consolidated EBITDA stood at Rs. 2,463 mn as compared to Rs. 1,893 mn in FY16, reflecting an increase of 30.2%

    • Consolidated EBITDA Margin was at 13.1% as compared to 11.7% in FY16, showing an improvement by 139 bps

    • PAT after minority interest and share in loss in associate stood at Rs. 831 mn as compared to Rs. 212 mn in FY16


    As on March 31st, 2017, the consolidated net debt was Rs. 1,826 mn representing a net debt to equity ratio of 0.19.


    Other Highlights during the Quarter




    • Narayana Institute of Cardiac Sciences, Bengaluru, became the first hospital in the country to introduce a new smart-generation catheter device that will correct electrical signals causing disturbance in the heart rhythm

    • Da Vinci Robotic Surgical System, installed at NH Health City, Bengaluru, crossed the milestone of performing over 150 surgeries within 10 months of its commissioning

    • Narayana Multispeciality Hospital, Raipur, performed the first Leadless Pacemaker Implant across Central India

    • NH entered into an agreement for healthcare services with ~300 capacity bedded Dharamshila Hospital & Research Centre to mark its maiden foray in NCR

    • The facility at Cayman Islands showcased exemplary performance achieving an EBITDA margin of 13.3% in Q4 FY17 translating to 7.6% EBITDA margin for the year. The unit achieved this feat within 3 years of its operations

    • Narayana Superspeciality Hospital, Howrah won the award for being “#1 Cancer Care Hospital in Eastern India” by Times of India Health Survey and Narayana Multispeciality Hospital, Mysore won AHPI Health Care Excellence Award in “Green Hospital” Category


    Management Comment


    Commenting on the performance, Dr. Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “We are pleased to demonstrate noteworthy performance in the quarter and the year gone by amidst the regulatory headwinds affecting our business on multiple counts.


    The steady ramp-up in our newer hospitals buoyed by the sustained performance of mature hospitals continue to drive our revenues, and at the same time, our changing business mix is improving our profitability profile.


    Overall, the fiscal year gone past illustrates substantial progress on the strategic goals that we have set for the group. The Indian healthcare landscape presents a unique opportunity to us as we take significant steps to become a true Pan-India healthcare provider.


    We believe that the government emphasis on “Health for All” is an important milestone and we remain confident that NH has positioned itself to make affordable quality healthcare accessible to all strata of society.”

    Consolidated total operating incomedebtDr Ashutosh RaghuvanshiEBITDAFinancial resultsIndian Accounting StandardsNarayana HrudayalayaNarayana Institute of Cardiac SciencesNarayana Multispeciality Hospital
    Source : PRESS RELEASE

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok